266 related articles for article (PubMed ID: 35323096)
1. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.
Dong C; Wu K; Gu S; Wang W; Xie S; Zhou Y
Cell Cycle; 2022 Jul; 21(13):1406-1421. PubMed ID: 35323096
[TBL] [Abstract][Full Text] [Related]
2. Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-β/Smad signaling pathway in lung adenocarcinaoma.
Deng G; Chen L; Zhang Y; Fan S; Li W; Lu J; Chen X
Exp Cell Res; 2018 Sep; 370(2):613-622. PubMed ID: 30031128
[TBL] [Abstract][Full Text] [Related]
3. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
4. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
[TBL] [Abstract][Full Text] [Related]
5. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
[TBL] [Abstract][Full Text] [Related]
6. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
[TBL] [Abstract][Full Text] [Related]
7. Quaking 5 suppresses TGF-β-induced EMT and cell invasion in lung adenocarcinoma.
Wang S; Tong X; Li C; Jin E; Su Z; Sun Z; Zhang W; Lei Z; Zhang HT
EMBO Rep; 2021 Jun; 22(6):e52079. PubMed ID: 33769671
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
9. CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.
Zhang J; Pan L; Zhang S; Yang Y; Liang J; Ma S; Wu Q
Clin Transl Oncol; 2023 Dec; 25(12):3527-3540. PubMed ID: 37249759
[TBL] [Abstract][Full Text] [Related]
10. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling.
Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
[TBL] [Abstract][Full Text] [Related]
11. PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.
Zhu N; Zhang XJ; Zou H; Zhang YY; Xia JW; Zhang P; Zhang YZ; Li J; Dong L; Wumaier G; Li SQ
Acta Pharmacol Sin; 2021 Aug; 42(8):1280-1287. PubMed ID: 33536603
[TBL] [Abstract][Full Text] [Related]
12. TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway.
Xiong Y; Feng Y; Zhao J; Lei J; Qiao T; Zhou Y; Lu Q; Jiang T; Jia L; Han Y
Cell Death Dis; 2021 Apr; 12(4):352. PubMed ID: 33824285
[TBL] [Abstract][Full Text] [Related]
13. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
Kim J; Hwan Kim S
PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
15. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma.
Du R; Wang C; Liu J; Wang K; Dai L; Shen W
BMC Cancer; 2023 Jan; 23(1):52. PubMed ID: 36647029
[TBL] [Abstract][Full Text] [Related]
17. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
[TBL] [Abstract][Full Text] [Related]
19. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
20. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
